Selected Publications
Nishwant Swami, Wei-Ting Hwang, Ronac Mamtani, Mark O'Hara, William Chapin: Real-world survival comparison of second-line treatment strategies for patients with RAS/RAF wild-type, right-sided metastatic colorectal cancer. Journal of Clinical Oncology 43 (4_suppl): 73,2025.
Margalit O, Stemmer A, Chapin WJ, Schacham-Shmueli E, Kopetz S, Andre T, Overman MJ, Pietrantonio F, Boursi B: Duration of Immunotherapy in dMMR/MSI-H Metastatic Colorectal Cancer Patients European Journal of Cancer 212 : 114336,2024.
Chapin WJ, Hwang W, Mamtani R, O’Hara MH: Real-world uptake and effectiveness of triplet versus doublet chemotherapy with bevacizumab in patients with metastatic colorectal cancer in the United States ESMO Gastrointestinal Oncology 5 : 100087,2024.
Chapin WJ, Hwang W, Mamtani R, O’Hara MH: Low- vs High-Dose 5-FU in Triplet Chemotherapy Plus Bevacizumab for Patients With Colorectal Cancer JAMA Netw Open 7 (7): e2424855,2024.
Rathore S, Reiss KA, Teitelbaum UR, Chapin WJ: Exploring the association of smoking status with clinical outcomes in patients with mPDAC treated on a clinical trial of maintenance niraparib plus immune checkpoint blockade. American Society of Clinical Oncology Annual Meeting, Chicago, IL. 42 (suppl 16): Abstract e16302,2024.
William Joseph Chapin, Wei-Ting Hwang, Ronac Mamtani, and Mark H. O'Hara: Real-world comparison of low- versus high-dose continuous 5FU infusion in patients receiving triplet chemotherapy plus bevacizumab for newly diagnosed metastatic colorectal cancer (mCRC). Journal of Clinical Oncology
42 (3_suppl): 62-62,2024.
William Joseph Chapin, Wei-Ting Hwang, Ronac Mamtani, Mark H O'Hara: Real-world comparison of triplet-versus doublet-chemotherapy with bevacizumab in patients with newly diagnosed metastatic colorectal cancer (mCRC). The American Society of Clinical Oncology Annual meeting, Chicago, IL. 41 (16_suppl): 3574-3574,2023.
William Joseph Chapin, Parul Agarwal, Lisa DiCicco, Rayleigh Palmer, Nadia Cenou, Alexander Chan Chi Huang, Thomas Benjamin Karasic: Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers. American Society of Clinical Oncology Annual Meeting, Chicago, IL. 41 (16_suppl): TPS4184-TPS4184,2023.
Alese OB, Wu C, Chapin WJ, Ulanja MB, Zheng-Lin B, Amankwah M, Eads J.: Update on Emerging Therapies for Advanced Colorectal Cancer Am Soc Clin Oncol Educ Book 43 : e389574. ,2023.
Chapin WJ, Hwang WT, Karasic TB, McCarthy AM, Kaplan DE.: Comparison of Nivolumab and Sorafenib for First Systemic Therapy in Patients with Hepatocellular Carcinoma and Child-Pugh B Cirrhosis Cancer Medicine 12 (1): 189-199.,2023.
Academic Contact Information
Perelman Center for Advanced Medicine
10 South Pavilion
3400 Civic Center Blvd
Philadelphia,
PA
19104
Patient appointments: 800-789-7366